Bobadilla Joseph L, Love Robert B, Jankowska-Gan Ewa, Xu Qingyong, Haynes Lynn D, Braun Ruedi K, Hayney Mary S, Munoz del Rio Alejandro, Meyer Keith, Greenspan Daniel S, Torrealba Jose, Heidler Kathleen M, Cummings Oscar W, Iwata Takekazu, Brand David, Presson Robert, Burlingham William J, Wilkes David S
Microbiology and Immunology, Director, Center for Immunobiology, Indiana University School of Medicine, Van Nuys Medical Sciences Building MS224, 635 Barnhill Drive, Indianapolis, IN 46202-5120, USA.
Am J Respir Crit Care Med. 2008 Mar 15;177(6):660-8. doi: 10.1164/rccm.200612-1901OC. Epub 2008 Jan 3.
The pathogenesis of primary graft dysfunction (PGD), a serious complication of lung transplantation, is poorly understood. Human studies and rodent models have shown that collagen type V (col[V]), stimulates IL-17-dependent cellular immunity after lung transplantation.
To determine whether patients with end-stage lung disease develop pretransplant col(V)-specific cellular immunity, and if so, the impact of this response on PGD.
Trans-vivo delayed-type hypersensitivity (TV-DTH) assays were used to evaluate memory T-cell responses to col(V) in 55 patients awaiting lung transplantation. Pa(O(2))/Fi(O(2)) index data were used to assess PGD. Univariate risk factor analysis was performed to identify variables associated with PGD. Rats immunized with col(V) or irrelevant antigen underwent lung isografting to determine if prior anti-col(V) immunity triggers PGD in the absence of alloreactivity.
We found that 58.8% (10/17) of patients with idiopathic pulmonary fibrosis, and 15.8% (6/38) of patients without idiopathic pulmonary fibrosis tested while on the wait list for a lung transplant were col(V) DTH positive. Col(V) reactivity was CD4(+) T-cell and monocyte mediated, and dependent on IL-17, IL-1beta, and tumor necrosis factor (TNF)-alpha. Pa(O(2))/Fi(O(2)) indices were impaired significantly 6-72 hours after transplantation in col(V)-reactive versus nonreactive patients. Univariate risk factor analysis identified only preoperative TV-DTH to col(V) and ischemic time as predictors of PGD. Finally, in a rat lung isograft model, col(V) sensitization resulted in significantly lower Pa(O(2))/Fi(O(2)), increased local TNF-alpha and IL-1beta production, and a moderate-to-severe bronchiolitis/vasculitis when compared with control isografts.
The data suggest that activation of innate immunity by col(V)-specific Th-17 memory cells represents a novel pathway to PGD after lung transplantation.
原发性移植肺功能障碍(PGD)是肺移植的一种严重并发症,其发病机制尚不清楚。人体研究和啮齿动物模型表明,Ⅴ型胶原(col[V])在肺移植后可刺激白细胞介素-17(IL-17)依赖的细胞免疫。
确定终末期肺病患者在移植前是否产生针对col(V)的细胞免疫,若产生,这种反应对PGD的影响。
采用体内迟发型超敏反应(TV-DTH)试验评估55例等待肺移植患者对col(V)的记忆性T细胞反应。采用动脉血氧分压(PaO₂)/吸入氧分数值(FiO₂)指数数据评估PGD。进行单因素危险因素分析以确定与PGD相关的变量。用col(V)或无关抗原免疫大鼠后进行肺同种异体移植,以确定预先存在的抗col(V)免疫在无同种异体反应性的情况下是否引发PGD。
我们发现,在等待肺移植名单上接受检测的特发性肺纤维化患者中有58.8%(10/17)、非特发性肺纤维化患者中有15.8%(6/38)的col(V) DTH呈阳性。col(V)反应由CD4⁺ T细胞和单核细胞介导,并依赖于IL-17、IL-1β和肿瘤坏死因子(TNF)-α。与无col(V)反应的患者相比,有col(V)反应的患者在移植后6至72小时动脉血氧分压(PaO₂)/吸入氧分数值(FiO₂)指数显著受损。单因素危险因素分析仅确定术前对col(V)的TV-DTH和缺血时间是PGD的预测因素。最后,在大鼠肺同种异体移植模型中,与对照同种异体移植相比,col(V)致敏导致动脉血氧分压(PaO₂)/吸入氧分数值(FiO₂)显著降低、局部TNF-α和IL-1β产生增加,以及中度至重度细支气管炎/血管炎。
数据表明,col(V)特异性Th-17记忆细胞激活固有免疫是肺移植后发生PGD的一条新途径。